Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback

Clinical trial NCT05214833 · UNKNOWN

Trial details

NCT number: NCT05214833
Sponsor: ETH Zurich
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Psychogenic Seizure Epilepsy, Temporal Lobe Health, Subjective

Start date: 2022-02-01
Primary completion: 2025-01-31
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.